Paper Details

  1. Home
  2. Paper Details

Angioplasty for dysfunctional arteriovenous fistulas: A meta-analysis of recent randomized controlled trials compared paclitaxel-coated balloon versus conventional balloon angioplasty.

Author: XiaCongying, YangQin

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Drug-coated balloon (DCB) angioplasty showed a trend toward a higher rate of target-lesion primary patency and a significantly lower rate of target-lesion reintervention compared to conventional balloon angioplasty in treating dysfunctional arteriovenous fistulas (AVF). DCB was non-inferior in terms of safety.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Stenosis in arteriovenous fistulas (AVF) due to neointimal hyperplasia is one of the most common causes of hemodialysis vascular access dysfunction. Treating patients with dysfunctional AVF with drug-coated balloon (DCB) angioplasty may potentially improve outcomes. OBJECTIVES: This sys...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/11297298231213724

データ提供：米国国立医学図書館（NLM）

Paclitaxel-Coated Balloons: A New Hope for Dysfunctional Arteriovenous Fistulas

Arteriovenous fistulas (AVF) are essential for hemodialysis patients, providing access for blood filtration. However, AVF dysfunction, often caused by neointimal hyperplasia, can significantly impact patient care. This meta-analysis explores the effectiveness and safety of paclitaxel-coated balloon (DCB) angioplasty compared to conventional balloon angioplasty for treating dysfunctional AVFs.

DCB Angioplasty: A Promising Treatment Option for AVF Dysfunction

The meta-analysis reveals that DCB angioplasty demonstrates a trend towards higher target-lesion primary patency (TLPP) rates and significantly lower target-lesion reintervention (TLR) rates compared to conventional balloon angioplasty. This suggests that DCB angioplasty could be a valuable treatment option for patients with dysfunctional AVFs, potentially improving outcomes and reducing the need for repeat interventions.

Improving AVF Outcomes: A Collaborative Effort

This meta-analysis emphasizes the importance of continued research and development of innovative treatment strategies for AVF dysfunction. It highlights the potential benefits of DCB angioplasty and underscores the need for standardized procedures and further research to optimize its effectiveness. This research is like a camel caravan crossing a vast desert of vascular access challenges, seeking solutions to improve patient outcomes and quality of life.

Dr.Camel's Conclusion

This meta-analysis is a journey through the desert of vascular access challenges, revealing the potential of DCB angioplasty to improve outcomes for patients with dysfunctional AVFs. By providing a comprehensive overview of current research, this meta-analysis guides us towards a future where innovative treatments can effectively address this complex problem, improving the lives of hemodialysis patients.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-12-05
Further Info :

Pubmed ID

38053229

DOI: Digital Object Identifier

10.1177/11297298231213724

Related Literature

Article Analysis
・Causes of angioplasty
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.